Sitagliptin Versus Placebo to Reduce the Incidence and Severity of Posttransplant Diabetes Mellitus After Kidney Transplantation—A Single-center, Randomized, Double-blind Controlled Trial
Sign Up to like & getrecommendations! Published in 2022 at "Transplantation"
DOI: 10.1097/tp.0000000000004373
Abstract: Background. Postkidney transplant diabetes mellitus (PTDM) affects cardiovascular, allograft, and recipient health. We tested whether early intervention with sitagliptin for hyperglycemia (blood glucose >200 mg/dL) within the first week of transplant and discontinued at 3… read more here.
Keywords: sitagliptin; arm; posttransplant; placebo ... See more keywords
Association between Posttransplant Opioid Use and Immunosuppressant Therapy Adherence among Renal Transplant Recipients
Sign Up to like & getrecommendations! Published in 2020 at "Nephron"
DOI: 10.1159/000507257
Abstract: Introduction: Little is known about the effect of posttransplant opioid use on adherence to immunosuppressant therapy (IST) among adult renal transplant recipients (RTRs). Objective: The aim of this study was to examine the relationship between… read more here.
Keywords: posttransplant; use; opioid use; renal transplant ... See more keywords